Page last updated: 2024-10-22

alendronate and Fever

alendronate has been researched along with Fever in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Research Excerpts

ExcerptRelevanceReference
" We report on a 35-year-old female who was diagnosed with TRAPS, after finding the V95M mutation on the TNFRSF1A gene; who was treated in order with etanercept, anakinra, and canakinumab (150 mg/every 8 weeks by subcutaneous injection, then increased to 150 mg every 4 weeks); and who started therapy with oral alendronate (70 mg/weekly) to control her osteoporosis."3.81Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. ( Cantarini, L; Frediani, B; Iannone, F; Lopalco, G; Rigante, D; Vitale, A, 2015)
"Alendronate is a potent bisphosphonate that has been studied for the treatment of osteoporosis and Paget's disease of the bone."2.69Pharmacokinetics of intravenous alendronate. ( Cocquyt, V; De Grève, J; DeSmet, M; Gertz, BJ; Holland, SD; Kline, WF; Porras, AG; Quan, H; Van Belle, SJ; Vyas, KP; Zhang, KE, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopalco, G1
Rigante, D1
Vitale, A1
Frediani, B1
Iannone, F1
Cantarini, L1
Cocquyt, V1
Kline, WF1
Gertz, BJ1
Van Belle, SJ1
Holland, SD1
DeSmet, M1
Quan, H1
Vyas, KP1
Zhang, KE1
De Grève, J1
Porras, AG1

Trials

1 trial available for alendronate and Fever

ArticleYear
Pharmacokinetics of intravenous alendronate.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:4

    Topics: Adult; Aged; Alendronate; Animals; Area Under Curve; Carbon Radioisotopes; Cricetinae; Dose-Response

1999

Other Studies

1 other study available for alendronate and Fever

ArticleYear
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
    Clinical rheumatology, 2015, Volume: 34, Issue:4

    Topics: Adult; Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combina

2015